Ivsins A, Boyd J, Mayer S, Collins A, Sutherland C, Kerr T, McNeil R Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study Drug Alcohol Depend, 2020. PubMed

Beaulieu T, Hayashi K, Dong H, DeBeck K, Day A, McKendry R, Kaur G, Barrios R, Milloy MJ, Ti L Impact of migration from an illicit drug scene on hospital outcomes among people who use illicit drugs in Vancouver, Canada Drug Alcohol Rev, 2020. PubMed

Rieb L, DeBeck K, Hayashi K, Wood E, Nosova E, Milloy MJ Withdrawal-associated injury site pain prevalence and correlates among opioid-using people who inject drugs in Vancouver, Canada Drug Alcohol Depend, 2020. PubMed

Raski M, Sutherland C, Brar R From methadone to Methadose: lessons learned from methadone formulation change in British Columbia Can Fam Physician, 2020. PubMed

Voon P, Wang L, Nosova E, Hayashi K, Milloy MJ, Wood E, Kerr T Greater pain severity is associated with inability to access addiction treatment among a cohort of people who use drugs J Pain Res, 2020. PubMed

Pearce L, Homayra F, Dale L, Moallef S, Barker B, Norton A, Hayashi K, Nosyk B Non-disclosure of drug use in outpatient health care settings: findings from a prospective cohort study in Vancouver, Canada Int J Drug Policy, 2020. PubMed

Reddon H, DeBeck K, Socías ME, Lake S, Dong H, Karamouzian M, Hayashi K, Kerr T, Milloy MJ Frequent cannabis use and cessation of injection of opioids, Vancouver, Canada, 2005-2018 Am J Public Health, 2020. PubMed

Ickowicz S, Dong H, Ti L, Nolan S, Fairbairn N, Barrios R, Milloy MJ Behavioural, social and structural-level risk factors for developing AIDS among HIV-positive people who use injection drugs in a Canadian setting, 1996-2017 AIDS Care, 2020. PubMed

Brar R, Grant C, DeBeck K, Milloy MJ, Fairbairn N, Wood E, Kerr T, Hayashi K Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada Am J Drug Alcohol Abuse, 2020. PubMed

Ickowicz S, Brar R, Nolan S Case study: naltrexone for the treatment of nitrous oxide use J Addict Med, 2020. PubMed